Introduction
One of the most frequent and most severe maternal complications in patients undergoing anesthesia in connection with cesarean section is aspiration of acid gastric contents leading to the development of a syndrome (MENDELSON'S) which is characterized by bronchospasm, progressive respiratory insuffiency, hypotonia and pulmonary edema [10, 12] . The severity of the syndrome depends on the volume and acidity of the aspirate [13] . The prevention of the syndrome has been based on reduction of the gastric content and its neutralization prior to induction of anesthesia.
Fasting and aspiration do not ensure an empty stomach. Administration of oral antacids for neutralization of the gastric contents is not advisable since aspiration of antacids causes a syndrome similar to that following aspiration of acid gastric contents [6] .
Cimetidine administered prior to induction of anesthesia has been demonstrated to be effective for the neutralization of gastric contents in both non-obstetric [11] and obstetric patients [12] . The placental transfer of cimetidine and its effect, if any, on the infants are poorly understood [9] . April 7, 1950 
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Material and method
The investigation was divided into two parts. Both parts were approved by the local ethical committee.
1. Primarily a prospective double-blind investigation comprising 39 consecutive patients undergoing cesarean section was carried out. Thirty-two patients underwent emergency cesarean section, and seven patients had elective cesarean sections. The indications appear in Tab. I. Twenty patients received cimetidine 400 mg (100 mg/ml, Tagamet®) intramuscularly of a mean of 75 minutes (30-195 minutes, range) before delivery. The remaining 19 patients were given 0.9% NaCl. After injection all patients were monitored with a cardiotocograph (HEWLETT-PACKARD, model 8030 A). The two groups did not differ in age, weight, parity or duration of pregnancy.
Tab. I. Distribution of indications for cesarean section in both groups. In some patients there were more than one indications.
Indications
NaCl Cimetidine After delivery the infants were placed in an incubator and observed continously, particularly for heart rate and respiratory function. For birth weight below 2500 g or in cases of severe intrauterine asphyxia, the infants were monitored with a cardioscope. Two hours after delivery K, Na, pH, Pco2, HCO^ and glucose levels were determined from capillary blood samples. During the second 24-hour period of life, fasting glucose was determined, and the infants underwent a complete physical and neurological examination by a pediatrician who repeated this examination at discharge. 2. In another study, eight patients with uncomplicated pregnancies were included. These patients did not participate in the first part of the study, and they underwent elective cesarean section because of breech presentation or prior cesarean section. One to two hours prior to delivery the patients received cimetidine 400 mg intramuscularly. At delivery samples of maternal venous blood were obtained together with venous cord blood samples for determination of the serum cimetidine concentration (SK & F Research Laboratories). One, thi^e and five hours after delivery blood samples from the infants were taken for determination of the serum concentration of cimetidine. The lower limits for quantitative determination of serum concentration of cimetidine was 0.03 mg/1. In a few cases only 1 ml of whole blood could be drawn from the infant, and in such cases, the lower limit of quantitation was fixed at 0.3 mg/1. All patients in both experiments were delivered under general anesthesia, as previously described [12] . Statistical analyses were performed using the Mann-Whitney rank-sum test for unpaired data and the X 2 -test.
Results
1.
Altogether 20 infants were delivered in the control group, and in the cimetidine group there were 21 infants. In the control group 3 patients underwent cesarean section because of imminent intrauterine asphyxia compared to 9 patients in the cimetidine group (0.2 > p > 0.1). In the cimetidine group, three infants with Apgar scores below 7 at one minute were delivered, as compared to one infant in the control group. In the patients with abnormal cardiotocogräph-ic tracings, no alterations or new changes were observed after injection. Observed changes are listed in Tab. II. After delivery no arrhythmias, or signs of respiratory depression were observed in the infants, and the values of K, Na, pH, Pco2, HCO J and glucose were nearly identical in the two groups (Tab. III). No signs of early cerebral changes were observed in any of the infants. All infants were found to be normal during the physical and neurological examination.
2. The evaluation of placental transfer of cimetidine revealed a concentration ratio of 3:1 between maternal venous blood and venous cord blood (Tab. IV). In 50 per cent of the infants, there was no trace of cimetidine one hour after delivery. In one infant cimetidine was found, but only at a very low and nonquantifiable level. In the remaining three infants the concentration ratio averaged 0.7 when measured one hour after delivery as compared to the value of venous cord blood. Subsequent samples at 3 and 5 hours after delivery showed no trace of cimetidine. None of the 8 infants presented abnormal findings after birth, and all had normal APGAR scores. The average birth weight was 3340 g.
Discussion
Cimetidine is a histamine H 2 receptor antagonist which is well known for the treatment of peptic ulcer where it blocks gastric acid secretion. Histamine H 2 receptors are present in many organs including the heart and the uterus. Animal experiments have not revealed any influence of cimetidine on the contractility pattern of the uterine muscles [2] and, following a single bolus injection, no electrocardiographic changes were observed [5] ; however, arrhythmias have been described following repeated doses administered to already ill and hypovolemic patients [3] . During the study, no pathological changes related to cimetidine were found in the contractility pattern of the uterus, the cardiotocographic tracings or blood samples from the infants. In the infants with low APGAR scores one minute after delivery, changes indicating severe intrauterine asphyxia were found prior to injection. The somewhat higher frequency of infants with low APGAR scores in the cimetidine group may be explained by the higher frequency of imminent fetal death as an indication for cesarean section in this group. All the infants had normal APGAR scores after 5 minutes and presented no early cerebral symptoms. To judge the condition of the newborns, we chosed the value for the APGAR score at 1 minute since this value has been found to correlate well with the values for pH, Tab. IV. Values for serum concentration of cimetidine (mg/1). Those results marked " are from blood samples with less than 1 ml whole blood (quantitation limit (0.3 mg/1). ND: Cimetidine could not be detected. Pco2 and base excess in umbilical artery blood [4] . McGowAN [9] found no effect of cimetidine on normal labor or any perinatal effects after intravenous administration of 200 mg of cimetidine. Others have reported similar results, although their groups were selected [8, 14] . In healthy adults most of the cimetidine is excreted unchanged in the urine, and the halflife of elimination is about 2 hours [7] . Similar conditions were observed in a premature infant who received cimetidine because of hemorrhagic gastritis [1] . In order to obtain exact values for the rate of elimination of cimetidine in the infants, we should have determined the cimetidine concentration in arterial cord blood; however, in only 50% of the infants was there 'detectable amounts of cimetidine one hour after delivery, and in none was? detected after 2 hours. This indicates rapid elimination. ZIEMNIAK et al. [15] found a half-life for cimetidine of 2.1 to 2.4 hours in two full-term infants.
Regarding the placental transfer of cimetidine, a fairly constant maternal/cord blood ratio of approximately 3 : 1 was found. McGowAN [9] found a ratio of 2 : 1 with very great variations.
Hence, since no changes in the course of delivery or perinatal effects on the infants were observed after administration of cimetidine, it is safe to use cimetidine as a prophylactic agent against the MENDELSON syndrome in patients undergoing cesarean section. The drug passes through the placenta at a maternal/cord blood ratio of about 3:1.
Summary
In a prospective randomized study of 39 consecutive cesarean sections, 20 patients received cimetidine 400 mg intramuscularly as a pre-anesthetic, an 19 controlpatients were given NaCl. No perinatal effects on the infants were observed by cafdiotocography before delivery, and K, Na, pH, Pco2, HCOJ and glucose values in capillary blood were nearly identical in the two groups 2 hours after birth, the difference being nonsignificant (p > 0.05). No respiratory effects or arrhythmias were observed. In another study comprising 8 elective cesarean sections in patients with uncomplicated pregnancies, cimetidine was found to cross the placenta at a maternal/cord blood ratio of 3 :1. The drug could not be detected in any of the infants 2 hours after delivery.
Keywords: Cesarean section, cimetidine, placenta, pre-anesthetic agent. Au cours d'une etude prospective randomisee de 39 cesariennes consecutives, 20 patientes ont regu 400 mg de cimetidine en pre-anesthesie et les contröles ont du NaCl. II n'a pas ete observe d'effets perinataux chez les enfants sur le cardiotocogramme realise avant la naissance, et les valeurs sur sang capillaire du K, du Na, du pH, de la Pcoi, des HCOJ et du glucose etaient pratiquemment identiques dans les 2 groupes apres la naissance, la difference etant noil significative (p > 0,05). II n'a pas ete observe d'effets respiratoires ni d'arythmies. Dans une autre etude portant sur 8 cesariennes chez des patientes ayant eu une grossesse sans complication, on a montre que la cimetidine traverse le placenta avec un rapport sang maternel/sang du cordon egal ä 3/1, et le medicament n'a pas pu etre detecte chez les enfants 2 heures apres la naissance.
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